Inulin Supplementation Reduces Systolic Blood Pressure in Women with Breast Cancer Undergoing Neoadjuvant Chemotherapy
Table 3
Frequency of women according to classification of blood pressure, HR, BMI, and BFP vs. supplementation group.
Placebo (n=19)
Inulin (n=19)
p
Baseline
After
Baseline
After
Baseline
After
SBP (mmHg)
≤ 120
5
6
2
2
0.071
0.251
120.1-130
8
5
4
7
130.1-140
0
2
5
5
≥140.1
6
6
8
5
DBP (mmHg)
< 89
17
15
18
18
0.999
0.340
> 90
2
4
1
1
MAP (mmHg)
< 102
12
17
13
19
0.999
0.486
>102.1
7
2
6
0
HR (BPM)
< 100
19
18
18
19
0.999
0.486
> 100.1
0
1
1
0
BMI (kg/m2)
Underweight
1
2
1
0
0.628
0.418
Normal
6
6
4
5
Overweight
8
9
7
7
Obese Class I
3
2
6
4
Obese Class II
1
0
0
1
Obese Class III
0
0
1
1
BFP ()
Normal
5
5
1
4
0.180
0.999
High
14
14
18
15
SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; HR: heart rate; BMI: body mass index; BFP: body fat percentage. BFP: normal ≤29.9; high ≥30. test: p<0.05.
